What It Is
MUSE-Infused RPA™ Therapy combines Regenerative Protein Array™ (RPA) technology with proteins extracted from MUSE cells. Because it’s acellular, it delivers regenerative proteins rather than living cells.
Regenerative Medicine & Orthobiologics
Advanced Acellular Regenerative Protein Therapy for Joint Health & Recovery
A specialized protein array enhanced with proteins naturally extracted from MUSE cells, designed to support communication between cells and coordinate the body’s natural repair processes.
Why patients choose us
Care built around you
- Acellular and non-DNA protein array
- Enhanced with proteins extracted from MUSE cells
- Delivered via IV push or targeted injection
- Supports cell signaling, not living-cell engraftment
- Physician-directed, personalized treatment plan
Our Expertise
What this service includes
How It Works
The proteins support direct biological signaling involved in tissue repair, anti-inflammatory activity, angiogenesis, and cytoprotective processes.
How It Differs From Traditional MUSE Cell Therapy
Traditional MUSE Cell Therapy uses living MUSE cells, while MUSE-Infused RPA Therapy uses an acellular protein fraction enhanced with proteins from MUSE cells.
How It Works
Five steps to relief
Comprehensive Consultation
Your physician performs an orthopedic evaluation and reviews your medical history, symptoms, imaging, and treatment goals.
Imaging & Diagnosis
Diagnostic tools help determine the most appropriate regenerative approach for your condition.
Customized Treatment Plan
Your physician develops a strategy based on your diagnosis, activity level, and lifestyle.
MUSE-Infused RPA™ Therapy
Your physician delivers the therapy through IV push or targeted injection to help support tissue repair and recovery.
Recovery & Follow-Up
Most patients return to light activities quickly, with scheduled monitoring appointments.
Conditions Treated
What this therapy is used for
- Knee osteoarthritis
- Hip osteoarthritis
- Shoulder arthritis
- Chronic tendon injuries
- Ligament injuries
- Persistent joint pain
- Sports injuries
- Inflammation management
Treatment Includes
What’s included
- Comprehensive orthopedic evaluation
- Review of diagnostic imaging
- Personalized regenerative treatment planning
- Physician-directed IV push or targeted injection
- Recovery recommendations
- Scheduled follow-up appointments
Pricing
- Initial consultation & imaging review
- $300
- Treatment starting from
- $2,500
The consultation fee is credited toward treatment. Pricing varies based on the treatment plan and physician recommendations. These are self-pay services and are not covered by insurance or Medicare.
Book a ConsultationPatient Guide & Answers
Common questions
What is MUSE-Infused RPA™ Therapy?
An acellular regenerative medicine treatment that combines Regenerative Protein Array™ technology with proteins extracted from MUSE cells to support the body’s natural healing response through protein signaling rather than living cells.
How is it different from Traditional MUSE Cell Therapy?
Traditional MUSE Cell Therapy uses living MUSE cells, while MUSE-Infused RPA Therapy uses an acellular protein fraction enhanced with proteins from MUSE cells.
How is treatment administered?
Treatment may be provided through IV push or targeted injection as part of your personalized treatment plan.
Who may be a candidate?
Your physician will determine whether MUSE-Infused RPA Therapy is appropriate after reviewing your symptoms, medical history, physical examination, and diagnostic imaging.
How long does treatment take?
Most regenerative medicine procedures are completed in under one hour, although treatment times vary depending on your individualized care plan.
Does insurance cover treatment?
Regenerative medicine therapies are generally self-pay services and are not covered by insurance or Medicare.
Protein-Driven Repair Signals
Find out if MUSE-Infused RPA™ therapy fits your recovery goals — consultation and imaging review is $300, credited toward treatment starting from $2,500.
Important Medical Information
None of the therapies described are FDA-approved to treat, cure or prevent any disease or condition, and they are not a substitute for indicated surgical care. Composition and mechanism characteristics are drawn from published literature and supplier documentation, not from RegenOrtho Palm Beach outcomes. Cellular products are HCT/Ps from accredited U.S. suppliers; per 21 C.F.R. § 1271.3(d) cell factors such as RPA are not classified as HCT/Ps. Donors are U.S.-based, screened and tested by third-party CLIA laboratories. Individual results vary and no outcome is guaranteed. This material is general education, not medical advice. Services are self-pay and are not covered by insurance or Medicare.